Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018
About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures
Research Beam adds a report titled “Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018” that provides detailed information of the Non-Hodgkin Lymphoma Therapeutics.The report is an excellent piece of study for investors who are looking towards the market.
Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die. However, in NHL they do not die; instead they grow and further divide. NHL can begin either in the T-cells or B-cells, though mostly it begins in the B-cells. The location of NHL is generally in the lymph nodes, but it can also spread to the body’s lymphatic system. It has many symptoms, of which swelling in the lymph nodes, abdominal pain, chest pain, cough, fever, fatigue, and night sweats are the most prominent. The causes of this disease are still unknown to scientists. NHL is linked with risk factors such as the overuse of immunosuppressant drugs, viruses such as HIV or Epstein-Barr, and bacteria such as Helicobacter pylori. NHL can be diagnosed by urine tests, physical examination for the enlargement of the lymph nodes, imaging tests (scans) such as magnetic resonance imaging (MRI) or computerized tomography (CT), and biopsy tests.
TechNavio's analysts forecast the Global Non-Hodgkin Lymphoma Therapeutics market will grow at a CAGR of 7.03 percent over the period 2014-2018.
Get Full Details On:http://www.researchbeam.com/global-non-hodgkin-lymphoma-therapeutics-2014-2018-market
294 views • 8 slides
